Last update 13 Dec 2024
INVENT Pharmaceuticals, Inc.

INVENT Pharmaceuticals, Inc.

Private Company|
California, United States
|
< 10
|
www.inventpharma.com

Overview

Tags

Other Diseases
Respiratory Diseases
Nervous System Diseases
Chemical drugs
Small molecule drug
Synthetic peptide

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases2
Nervous System Diseases1
Neoplasms1
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Chemical drugs6
Small molecule drug3
Synthetic peptide1
Top 5 TargetCount
ACE2 x Exopeptidase1
GLP-1R(Glucagon-like peptide 1 receptor)1
SARS-CoV-2 3CLpro(SARS-CoV-2-3C-like-proteinase)1
GPCR(G-protein coupled receptor)1

Related

10
Drugs associated with INVENT Pharmaceuticals, Inc.
INV-290
Target-
Mechanism-
Active Org.
INVENT Pharmaceuticals, Inc.INVENT Pharmaceuticals, Inc.
Originator Org.
INVENT Pharmaceuticals, Inc.INVENT Pharmaceuticals, Inc.
Active Indication
Neuroendocrine Tumors
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
INV-331
Target-
Mechanism-
Active Org.
INVENT Pharmaceuticals, Inc.INVENT Pharmaceuticals, Inc.
Originator Org.
INVENT Pharmaceuticals, Inc.INVENT Pharmaceuticals, Inc.
Active Indication
Alzheimer Disease [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
INV-550
Target
ACE2 x Exopeptidase
Mechanism
ACE2 inhibitors [+1]
Active Org.
INVENT Pharmaceuticals, Inc.INVENT Pharmaceuticals, Inc.
Originator Org.
INVENT Pharmaceuticals, Inc.INVENT Pharmaceuticals, Inc.
Active Indication
COVID-19
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with INVENT Pharmaceuticals, Inc.
Login to view more data
0 Patents (Medical) associated with INVENT Pharmaceuticals, Inc.
Login to view more data
100 Deals associated with INVENT Pharmaceuticals, Inc.
Login to view more data
100 Translational Medicine associated with INVENT Pharmaceuticals, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 19 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
10
2
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
INV-407
Attention Deficit Disorder With Hyperactivity
More
Preclinical
INV-331
Alzheimer Disease
More
Preclinical
INV-290
Neuroendocrine Tumors
More
Preclinical
INV-550
 ( ACE2 x Exopeptidase )		COVID-19
More
Preclinical
INV-270
Pulmonary Fibrosis
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free